Technology
November 5, 2010 - The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the latest version of a cardiovascular ultrasound system. The GE Healthcare Vivid E9 Breakthrough 2011 (BT11) is built for 4-D imaging and features elements designed to help improve image quality, quantification and workflow.
November 05, 2010
News
November 4, 2010 – GE Healthcare has signed an exclusive collaboration agreement with West Physics Consulting to provide accreditation support. The agreement will support customers seeking accreditation from the American College of Radiology (ACR) for MRI, CT, nuclear medicine and PET systems.
November 04, 2010
Technology
November 3, 2010 – The U.S. Food and Drug Administration (FDA) has approved a new stent delivery system for clinical practice in the United States. The Talent Thoracic Stent Graft with Captivia delivery system, by Medtronic, features a tip capture mechanism for controlled deployment and precise placement of the implantable medical device.
November 03, 2010Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
November 3, 2010 – A multicenter CE-mark study has been launched for transapical TAVI system. Hendrik Treede, M.D., performed the first implantations of the system, made by JenaValve, at the Universitäres Herzzentrum Hamburg.
November 03, 2010
News
November 3, 2010 – The first patient has been enrolled into a study comparing a left atrial appendage (LAA) closure device to warfarin therapy in those with atrial fibrillation. The PREVAIL study will look at Atritech’s Watchman LAA closure device. Central Baptist Hospital in Lexington, Ky., enrolled the first patient.
November 03, 2010News
November 2, 2010 – Boston Scientific will sell its neurovascular business to Stryker for $1.5 billion in cash. Of that purchase price, $1.4 billion will be paid at closing, and the remaining $100 million will be paid upon commercialization of the Target Detachable Coils. Several manufacturing facilities will also be transferred to Stryker.
November 01, 2010Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
November 1, 2010 - After a heart attack victim stops breathing, a process of irreversible brain damage starts to occur within three to four minutes. But a new technique may significantly delay that damage.
November 01, 2010Technology
Several upgrades are now available on Toshiba’s Viamo ultrasound system, including ApliPure Plus, Tissue Pure Imaging, a ...
November 01, 2010Technology
The Titan 3T is a works-in-progress magnetic resonance (MR) system from Toshiba. The system has several patient-friendly ...
November 01, 2010Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023Technology
A works-in-progress 160-detector row helical computed tomography (CT) scanning system is being unveiled on the Toshiba ...
November 01, 2010Technology
Target CTA and the works-in-progress Adaptive Iterative Dose Reduction (AIDR) technology, by Toshiba, lower radiation ...
November 01, 2010
Technology
The Siemens Acuson S2000 ultrasound system, release 2.0, is a multi-specialty platform featuring 2-D and color Doppler ...
November 01, 2010Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
The syngo.via imaging software, by Siemens, enables physicians to access advanced visualization tools across the ...
November 01, 2010
News
The first-in-man use of the Coherex WaveCrest left atrial appendage (LAA) occluder system was successfully performed recently in New Zealand, launching the WAVECREST 1 trial to evaluate the device's effectiveness. The trial is being carried out in New Zealand, Australia and several European countries and will be used to seek CE mark approval for the device.
October 29, 2010News
October 29, 2010 – Site enrollment has been completed for the 50-site CITADEL and CENTURION clinical studies to evaluate the Tyrx AigisRx Antibacterial Envelope. The device is designed to help reduce surgical-site infections (SSIs) associated with cardiac implantable electronic devices (CIEDs).
October 29, 2010© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now